Build status - In Progress

Evaluating Study Drug BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Recruiting
18 years - 99 years
All
10 participants needed
1 Location

Brief description of study

This study is being done to test the safety, effectiveness, and side effects of 2 different doses of the study drug, BI 1015550, when compared to taking a placebo, in subjects with PF-ILD. In this study you will either get the active study drug, BI 1015550 or a placebo. If you join this study, there will be a Screening Period, a Study Drug Period, an End of Treatment Visit, and a Follow-up Period. Participants will be paid $150 for all study visits.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Lung Disease
  • Age: 18 years - 99 years
  • Gender: All
Updated on 04 Aug 2024. Study ID: 852132

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center